CNS PNET molecular subgroups with distinct clinical features.

作者信息

von Bueren André O

出版信息

Lancet Oncol. 2012 Aug;13(8):753-4. doi: 10.1016/S1470-2045(12)70260-7. Epub 2012 Jun 11.

DOI:10.1016/S1470-2045(12)70260-7

PMID:22691719

Abstract

摘要

相似文献

CNS PNET molecular subgroups with distinct clinical features.

Lancet Oncol. 2012 Aug;13(8):753-4. doi: 10.1016/S1470-2045(12)70260-7. Epub 2012 Jun 11.

Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis.

Lancet Oncol. 2012 Aug;13(8):838-48. doi: 10.1016/S1470-2045(12)70257-7. Epub 2012 Jun 11.

Expression of neurogenic basic helix-loop-helix genes in primitive neuroectodermal tumors.

Cancer Res. 1997 Aug 15;57(16):3526-31.

Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors.

Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10851-6. doi: 10.1073/pnas.181340798. Epub 2001 Aug 28.

Review: In vivo models for defining molecular subtypes of the primitive neuroectodermal tumor genome: current challenges and solutions.

In Vivo. 2012 Jul-Aug;26(4):487-500.

MEK Inhibitors Reverse Growth of Embryonal Brain Tumors Derived from Oligoneural Precursor Cells.

Cell Rep. 2016 Oct 25;17(5):1255-1264. doi: 10.1016/j.celrep.2016.09.081.

Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors.

Cancer Res. 2019 Mar 1;79(5):905-917. doi: 10.1158/0008-5472.CAN-18-1261. Epub 2019 Jan 23.

Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome.

J Clin Oncol. 1998 Jul;16(7):2478-85. doi: 10.1200/JCO.1998.16.7.2478.

The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.

J Neuropathol Exp Neurol. 2004 May;63(5):499-509. doi: 10.1093/jnen/63.5.499.

Rhabdoid tumor of the kidney with primitive neuroectodermal tumor of the central nervous system: associated tumors with different histologic, cytogenetic, and molecular findings.

Genes Chromosomes Cancer. 1994 Nov;11(3):146-52. doi: 10.1002/gcc.2870110303.

引用本文的文献

Treatment Outcome and Prognostic Molecular Markers of Supratentorial Primitive Neuroectodermal Tumors.

PLoS One. 2016 Apr 13;11(4):e0153443. doi: 10.1371/journal.pone.0153443. eCollection 2016.

MYCN amplification predicts poor outcome for patients with supratentorial primitive neuroectodermal tumors of the central nervous system .

Neuro Oncol. 2014 Jul;16(7):924-32. doi: 10.1093/neuonc/not302.

Primary primitive neuroectodermal tumor of the cervix.

Onco Targets Ther. 2013 Jun 17;6:707-11. doi: 10.2147/OTT.S45889. Print 2013.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验